Asia Pacific Pediatric Diabetes Management Market Size & Outlook
Related Markets
Asia Pacific pediatric diabetes management market highlights
- The Asia Pacific pediatric diabetes management market generated a revenue of USD 1,229.9 million in 2024.
- The market is expected to grow at a CAGR of 10.6% from 2025 to 2033.
- In terms of segment, cgm was the largest revenue generating product in 2024.
- CGM is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 1,229.9 million |
| Market revenue in 2033 | USD 3,051.1 million |
| Growth rate | 10.6% (CAGR from 2025 to 2033) |
| Largest segment | Cgm |
| Fastest growing segment | CGM |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | BGM, CGM, Insulin Pumps, Insulin Pens, Insulin Syringes |
| Key market players worldwide | Medtronic PLC, DexCom Inc, Abbott, Tandem Diabetes Care Inc, Insulet Corp, Novo Nordisk A/S, Sanofi SA, Eli Lilly, Roche Diabetes Care, Ascensia Diabetes Care |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.0% of the global pediatric diabetes management market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,051.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pediatric Diabetes Management Market Scope
Pediatric Diabetes Management Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Diabetes Care | View profile | 5001-10000 | Burgdorf, Bern, Switzerland, Europe | https://www.rochediabetes.com/ |
| Eli Lilly | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Ascensia Diabetes Care | View profile | 1001-5000 | Basel, Basel-Stadt, Switzerland, Europe | http://www.ascensia.com/ |
| DexCom Inc | View profile | 9600 | 6340 Sequence Drive, San Diego, CA, United States, 92121 | https://www.dexcom.com |
| Tandem Diabetes Care Inc | View profile | 2400 | 12400 High Bluff Drive, San Diego, CA, United States, 92130 | https://www.tandemdiabetes.com |
| Insulet Corp | View profile | 3000 | 100 Nagog Park, Acton, MA, United States, 01720 | https://www.insulet.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
Asia Pacific pediatric diabetes management market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pediatric diabetes management market will help companies and investors design strategic landscapes.
Cgm was the largest segment with a revenue share of 38.43% in 2024. Horizon Databook has segmented the Asia Pacific pediatric diabetes management market based on bgm, cgm, insulin pumps, insulin pens, insulin syringes covering the revenue growth of each sub-segment from 2021 to 2033.
The Asia Pacific region is witnessing the fastest CAGR growth in the pediatric diabetes management market. This can be attributed to the increasing prevalence of childhood obesity and unhealthy dietary habits, coupled with a rising awareness of diabetes among parents.
Moreover, the market is expected to expand due to improved healthcare infrastructure, increased government initiatives promoting early diagnosis and treatment, and the growing adoption of advanced diabetes management technologies, such as continuous glucose monitoring (CGM) systems and insulin pumps, across the region.
Reasons to subscribe to Asia Pacific pediatric diabetes management market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific pediatric diabetes management market databook
-
Our clientele includes a mix of pediatric diabetes management market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pediatric diabetes management market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pediatric diabetes management market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific pediatric diabetes management market size, by country, 2021-2033 (US$M)
Asia Pacific Pediatric Diabetes Management Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
